A capital funding round has brought in $38 million from new and existing private investors for restor3d.
Restor3d, which manufactures personalized orthopedic implants, will use the investment to launch four 3D-printed orthopedic product lines in 2025 and 2026, according to an April 4 news release.
The new products are the Veritas reverse total shoulder system, the iTotal identity 3DP porous cementless total knee, the Kinos modular stem total ankle system and the Velora 3DP porous acetabular system.
The shoulder system is a single-tray instrument system that will make patient-specific implants accessible to a wider shoulder patient population. It is awaiting FDA approval.
The total knee system is the first fully cementless, patient-specific knee system, and it recently received FDA clearance.
The ankle system earned FDA clearance in late 2024 and is optimized for delivery through an anterior approach, providing enhanced surgical flexibility and personalized fit.
The acetabular system is a porous hip cup designed to promote osseointegration by incorporating TIDAL Technology and long-term stability in hip arthroplasty procedures; it is also awaiting FDA approval, the release said.
